Falcone R C, Aharony D, Orzechowski R F
Department of Pharmacology and Toxicology, Philadelphia College of Pharmacy and Science, Pennsylvania.
J Pharmacol Exp Ther. 1991 Jul 1;258(1):199-206.
The effects of peptidoleukotrienes (LTs) on electrically driven guinea pig left atria (GPLA) were investigated. LTD4 produced a positive inotropic response; however, rapid desensitization required the construction of noncumulative dose-response curves to naive tissues. The maximal inotropic response to LTD4 was 24 +/- 3% of isoproterenol and the EC50 = 267 +/- 77 nM. The functional response was corroborated by the demonstration of specific and rapid [3H]LTD4 binding to GPLA membranes with low affinity (Kd = 212 +/- 80.2 nM), in a saturable (Bmax = 20 +/- 1.1 pmol/mg protein) manner. In tissues pretreated with acivicin, which inhibits conversion of LTC4 to LTD4, the response to LTC4, but not LTD4, was abolished. Selectivity towards LTD4 was demonstrated by the inability of propranolol, prazosin, atropine, pyrilamine, capsaicin or indomethacin (all tested at 1 microM) to alter the functional response to LTD4. Similarly, none of the tested compounds (100 microMs) was inhibitory in the binding assay. Structurally diverse LTD4 antagonists SKF102922 (pKb = 6.42) and ICI 198.615 (pKb = 8.74) were able to inhibit the functional response as well as [3H]LTD4 binding to GPLA membranes. The calcium channel antagonist, verapamil, inhibited the functional response but did not alter [3H]LTD4 binding. These data support the existence of specific LTD4 receptors in GPLA which evoke a modest, rapidly desensitized, increase in the force of myocardial contraction.
研究了肽白三烯(LTs)对电驱动豚鼠左心房(GPLA)的影响。LTD4产生正性肌力反应;然而,由于快速脱敏,需要构建对未处理组织的非累积剂量反应曲线。对LTD4的最大肌力反应为异丙肾上腺素的24±3%,EC50 = 267±77 nM。通过证明[3H]LTD4以低亲和力(Kd = 212±80.2 nM)特异性且快速地与GPLA膜结合,并呈饱和状态(Bmax = 20±1.1 pmol/mg蛋白),证实了功能反应。在用阿西维辛预处理的组织中,阿西维辛抑制LTC4向LTD4的转化,对LTC4的反应被消除,但对LTD4的反应未受影响。普萘洛尔、哌唑嗪、阿托品、吡拉明、辣椒素或吲哚美辛(均在1 μM下测试)均不能改变对LTD4的功能反应,证明了对LTD4的选择性。同样,在结合试验中,所测试的化合物(100 μM)均无抑制作用。结构多样的LTD4拮抗剂SKF102922(pKb = 6.42)和ICI 198.615(pKb = 8.74)能够抑制功能反应以及[3H]LTD4与GPLA膜的结合。钙通道拮抗剂维拉帕米抑制功能反应,但不改变[3H]LTD4的结合。这些数据支持GPLA中存在特异性LTD4受体,该受体可引起适度的、快速脱敏的心肌收缩力增加。